title: [Experience of surgical resection of Bismuth-Corlette type I and II hilar cholangiocarcinoma].
abstract: OBJECTIVE
  To report the experience of surgical resection of Bismuth-Corlette type I and II hilar cholangiocarcinoma.
  
  
  METHODS
  From January 1998 and January 2008, 52 cases of Bismuth-Corlette type I and II hilar cholangiocarcinoma were operated on. The clinical data and long-term outcome of the patients was retrospectively analyzed.
  
  
  RESULTS
  Of the 52 cases, 44 cases (84.6%) received operation, 28 patients underwent radical resection (63.6%) and 16 patients (36.4%) underwent palliative resection.Seven patients were resected on caudate lobe and other section and lobe of the liver; among them, 2 patients received combined portal vein resection and 4 underwent combined hepatic artery resection respectively. Eleven cases developed postoperative complications and another one died in hospital. The median survival was 33.2 months in radical resection group, and 1-, 3-, 5-year survival rate was 82.6%, 47.8%, 34.7%, respectively, which was significant greater than those in the palliative resection group (41.6%, 16.6%, 8.3%, respectively) (P < 0.05). The median survival was 16.7 months in the palliative resection group.
  
  
  CONCLUSIONS
  The radical resection is still the best treatment for Bismuth-Corlette type I and II hilar cholangiocarcinoma. Intraoperative pathology for resection margin, and combined liver resection, portal vein resection and hepatic artery resection can help improve the radical resection rate.
authors.affiliation: Department of General Surgery, First Affiliated Hospital, Shanxi Medical University, Taiyuan 030001, China. haoliangzhao@hotmail.com
authors.forename: Hao-liang
authors.initials: HL
authors.lastname: Zhao
authors.forename: Zhi-gang
authors.initials: ZG
authors.lastname: Wei
authors.forename: Jie-feng
authors.initials: JF
authors.lastname: He
authors.forename: Jian-sheng
authors.initials: JS
authors.lastname: Liu
authors.forename: Ying
authors.initials: Y
authors.lastname: Zhao
authors.forename: Min-sheng
authors.initials: MS
authors.lastname: Bao
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001650:Bile Duct Neoplasms / Q000601:surgery*; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006498:Hepatectomy; D006499:Hepatic Artery / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D011169:Portal Vein / Q000601:surgery; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate